10th Annual Mobile Tech in Clinical Trials: What to Expect in under 10 Minutes
Directors, Valerie Bowling and Kate Woda, discuss what to expect at the upcoming 10th annual Mobile Tech in Clinical Trials conference taking place on September 19, 2023 in Boston, MA.
28 Jul 20239min
CRAACO Director's Note Podcast on What to Expect in Under 6 Minutes
Director, Valerie Bowling, reviews what to expect at the upcoming Clinical Research as a Care Option (CRAACO) conference taking place on May 22-23 at the Sheraton Imperial Hotel in Raleigh-Durham, NC.
10 Mai 20236min
Current Challenges in Vaccine Delivery and Distribution
In this podcast, you will hear a panel discussion moderated by Paul Jansen from the 2022 PODD Conference regarding the biggest challenges as well as future solutions to vaccine administration and dist...
23 Jan 202329min
Providing the Right Level of Value to the Patient that Creates Value
In this podcast, you will hear a panel discussion moderated by Mark DeStefano, Teva, from the 2022 PODD Conference regarding balancing the level of connected activity with user needs, determining how ...
20 Jan 202328min
Enhancing the Interferon Pathway to Attack Cancer
Why is enhancing the interferon pathway an attractive approach for treating cancer?What are the novel therapeutic approaches being investigated to harness the innate immune system to enhance the inter...
19 Jan 202320min
Innovative CRISPR-based Editing to Create Off-the-shelf Immune Cell Therapies
In this talk, first recorded at the 2022 IO360° Summit, Dr Rachel Haurwitz, CEO, Caribou Biosciences, addresses the big picture view of where the cell therapy field is going and how innovative CRISPR-...
18 Jan 202326min
Investment Trends in IO
Moderated by: Axel Hoos, MD, PhD, CEO, Scorpion Therapeutics Panelists: Jonathan Fassberg, Vice Chairman of Healthcare Investment Banking, OppenheimerIrina Margine, PhD, Principal, Biotech Private E...
17 Jan 202345min
Investment and Collaboration Strategies in Cell and Gene Therapy
This panel, first recorded at the 2022 IO360° Summit addressed: What are the risks and implications of investing in cell/gene therapy companies who have no clinical data from programs available?Ventur...
16 Jan 202342min
